全文获取类型
收费全文 | 186篇 |
免费 | 5篇 |
国内免费 | 4篇 |
专业分类
儿科学 | 13篇 |
妇产科学 | 2篇 |
基础医学 | 22篇 |
口腔科学 | 7篇 |
临床医学 | 14篇 |
内科学 | 35篇 |
皮肤病学 | 2篇 |
神经病学 | 4篇 |
特种医学 | 50篇 |
外科学 | 6篇 |
综合类 | 7篇 |
预防医学 | 8篇 |
眼科学 | 3篇 |
药学 | 20篇 |
肿瘤学 | 2篇 |
出版年
2022年 | 1篇 |
2021年 | 5篇 |
2019年 | 4篇 |
2018年 | 1篇 |
2017年 | 1篇 |
2016年 | 3篇 |
2015年 | 4篇 |
2014年 | 9篇 |
2013年 | 6篇 |
2012年 | 1篇 |
2011年 | 1篇 |
2010年 | 6篇 |
2009年 | 3篇 |
2008年 | 3篇 |
2007年 | 4篇 |
2006年 | 3篇 |
2005年 | 9篇 |
2004年 | 4篇 |
2003年 | 3篇 |
2002年 | 3篇 |
2001年 | 1篇 |
1999年 | 3篇 |
1998年 | 14篇 |
1997年 | 13篇 |
1996年 | 16篇 |
1995年 | 8篇 |
1994年 | 8篇 |
1993年 | 15篇 |
1992年 | 3篇 |
1991年 | 2篇 |
1990年 | 3篇 |
1989年 | 9篇 |
1988年 | 5篇 |
1987年 | 3篇 |
1986年 | 2篇 |
1985年 | 3篇 |
1984年 | 2篇 |
1983年 | 3篇 |
1981年 | 1篇 |
1980年 | 2篇 |
1979年 | 1篇 |
1977年 | 2篇 |
1976年 | 2篇 |
排序方式: 共有195条查询结果,搜索用时 15 毫秒
161.
Bardhan KD; Nayyar AK; Royston C 《QJM : monthly journal of the Association of Physicians》1998,91(3):231-237
We studied 2119 patients presenting with duodenal ulcer as sole lesion, in
the period 1976-1993, the era of H2 receptor antagonist (H2RA) therapy,
prior to the introduction of Helicobacter pylori eradication. We used
clinical assessment and serial check endoscopy to investigate the incidence
of bleeding at presentation (group I, n = 286, 13.5%), the long-term
outcome in this group and in that presenting with pain alone (group II, n =
1833, 87%) with respect to ulcer recurrence and bleeding, and the effect of
H2RA maintenance therapy. Most patients were treated with H2RA, principally
cimetidine. In group I, seven patients died early on; 38 had urgent
surgery, of whom six died post- operatively. The remainder were treated;
five immediately re-bled, of whom three were operated on. On follow-up,
98/227 group I patients relapsed, 21 (21%) of whom rebled. Relapse in group
II was 1017/1668, with only 42 (4%) bleeding (p < 0.001). In patients
without maintenance treatment, relapse was markedly higher (50/78 group I,
529/742 group II), but group II still bled significantly less (20% group I
vs. 3% group II). Relapse on maintenance was: 48/149 with five (10%)
rebleeding in group I, and 488/926 with five (1%) bleeding in group II (p
< 0.001). Despite the introduction of H2RA therapy, patients presenting
with haemorrhage still have a risk of bleeding at ulcer relapse about
7-fold higher than that for those presenting with pain alone.
相似文献
162.
163.
LT Goodnough ; TH Price ; KD Friedman ; M Johnston ; D Ciavarella ; N Khan ; R Sacher ; WR Vogler ; M Wissel ; RI Abels 《Transfusion》1994,34(1):66-71
BACKGROUND: Previous clinical trials have shown that the use of recombinant human erythropoietin (EPO) can facilitate autologous blood donation and reduce allogeneic blood transfusions in autologous blood donors who are anemic at first donation. However, the role of EPO therapy in nonanemic patients remains undefined. To identify this role, a randomized, controlled, multicenter dose-escalation trial was conducted in patients whose initial hematocrit was > 39 percent (0.39). STUDY DESIGN AND METHODS: EPO (150, 300, or 600 units/kg) or placebo was administered intravenously at each of six phlebotomy visits over a 3-week study period. Sixteen (14%) of 116 patients were unable to complete the treatment protocol because of adverse events (n = 11) or for personal reasons (n = 5); 2 patients (1 EPO and 1 placebo) experienced serious adverse events. RESULTS: In 91 evaluable patients, additional red cell production during the study period was 440 +/− 176, 621 +/− 215, 644 +/− 196, and 856 +/− 206 mL (mean +/− SD), respectively, for patients receiving placebo and EPO at 150, 300, and 600 units/kg (p < 0.05 for all EPO groups compared to placebo). However, the percentages of patients in each group who received allogeneic blood did not differ: 2 (9%) of 23 placebo patients and 6 (9%) of 68 EPO patients. CONCLUSION: It is concluded that, while EPO therapy increased preoperative red cell production, no clinical benefit could be demonstrated in autologous blood donors who were not anemic at first blood donation. 相似文献
164.
JE Donachy KD Brannon LS Hughes J Seahorn TT Crutcher 《Disability and rehabilitation》2013,35(8):495-499
Purpose:?The purpose of this article is to describe the development of a strength and endurance training programme designed to prepare an individual with a left glenohumeral disarticulation and transtibial amputation for a bike trip across the USA.Method:?The subject was scheduled for training three times per week over a two-month period followed by two times per week for an additional two months. Training consisted of a resistance training circuit using variable resistance machines, cycling using a recumbent stationary bike, and core stability training using stability ball exercises. Changes in strength were assessed using 10 RM tests on the resistance machines and changes in peak VO2 were monitored utilizing the Cosmed K4b2® pulmonary function tester.Results:?The subject demonstrated a 30.3% gain in peak VO2. The subject's 10 RM for left single limb leg press increased 36.8% and gains of at least 7.7% were seen for all other muscle groups tested.Conclusion:?The strength and endurance training programme adapted to compensate for this subject's limb losses was effective in increasing both strength and peak VO2. Adapting exercise programmes to compensate for limb loss may allow individuals with amputations to participate in physically challenging activities that otherwise may not be available to them. 相似文献
165.
166.
167.
In rabbits receiving a normal laboratory diet the platelet half-life was 40.4 ± 2.5h (mean ± S.D., N=35). In animals fed the cholesterolenriched diet for 12 weeks the platelet half-life was reduced to 31.6 ± 3.6h (mean ± S.D., N=35). Treatment of cholesterol-fed animals with a single daily dose of CGS 12970 (a long acting inhibitor of thromboxane synthase) normalised the platelet half-life. Single daily doses of the relatively shorter acting thromboxane synthase inhibitors (CGS 13080 and dazoxiben) failed to correct the reduced platelet survival. However, twice daily dosing with dazoxiben was effective. The cyclooxygenase inhibitors, aspirin and sulphinpyrazone, failed to correct the reduced platelet survival. 相似文献
168.
Stereotactic breast biopsy with a biopsy gun 总被引:37,自引:1,他引:36
Parker SH; Lovin JD; Jobe WE; Luethke JM; Hopper KD; Yakes WF; Burke BJ 《Radiology》1990,176(3):741-747
One hundred three patients underwent stereotactic breast biopsy with an 18-, 16-, or 14-gauge cutting needle and a biopsy gun. After biopsy, a localization wire was placed and surgical biopsy performed. There was agreement of the histologic results in 89 cases (87%) including 14 of 16 cancers (87%) (kappa = 0.806). The gun biopsy yielded the correct diagnosis in four cases involving a lesion (including one cancer) that was missed at the surgical biopsy. Nine cases in which the lesion was missed at gun biopsy can be related to insufficient needle size, the greater difficulty in using one of the two stereotactic devices, and early inexperience with the technique. A 14-gauge needle was used in the last 29 biopsies, the results of which agreed with the surgical pathologic findings in 28 cases (97%). With greater experience, stereotactic-guided large-gauge automated percutaneous biopsy may prove to be an acceptable alternative to surgical biopsy in women with breast masses suspected at mammography. 相似文献
169.
170.
Winter JN; Andersen J; Variakojis D; Gordon LI; Fisher RI; Oken MM; Neiman RS; Jiang S; Bauer KD 《Blood》1996,88(10):3919-3925
The International Index is a powerful predictor of outcome in the aggressive non-Hodgkin's lymphomas that is based solely on clinical features. Proliferative activity (% S-phase) measured by flow cytometry has been reported to have prognostic significance in many series and may represent a biologic correlate of clinical behavior that further defines prognosis. Flow cytometric analysis of cellular DNA content and proliferative activity (% S-phase) was performed on fixed paraffin- embedded biopsy specimens from 242 previously untreated patients with diffuse, aggressive non-Hodgkin's lymphomas entered on phase III intergroup clinical trials. The International Index was calculated for each patient based on stage, lactate dehydrogenase, performance status, number of extranodal sites, and age, as previously reported. The International Index consistently predicted response to therapy (P = .027) and survival (P = .007) in this series. DNA aneuploidy was shown in 57% of cases, but was not predictive of clinical outcome. The median % S-phase was 9.9 (median coefficient of variation, 3.6%), which was highly correlated with mitotic index (P = .0001). Although a trend associating low proliferative activity with good early survival and very high S-phase with a shortened survival was shown, International Index risk was the only significant predictor of survival in the multivariate analysis. Although proliferative activity quantitated by flow cytometric analysis of nuclei extracted from paraffin-embedded specimens is probably predictive of survival, it is a less powerful prognostic indicator than clinical parameters represented by the International Index and provides no additional prognostic information. 相似文献